Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Two siblings both had a rare case of alopecia areata at the same time.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

CD2 might be a new treatment target for patchy alopecia areata.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.